Cited by 2,542Cancer Genomics and DiagnosticsCancer Cells and MetastasisMicrofluidic and Bio-sensing Technologies

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Allard, W. Jeffrey, Matera, Jeri, Miller, M. Craig, Repollet, Madeline, Connelly, Mark C., Rao, Chandra, Tibbe, Arjan G. J., Uhr, Jonathan W., Terstappen, Leon W. M. M.·2004·Clinical Cancer Research

DOI 10.1158/1078-0432.ccr-04-0378

Published version of a preprint

Open this paper in CoChat — free account

Abstract

PURPOSE: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate the number of circulating tumor cells (CTCs) per 7.5 mL of blood in healthy subjects, patients with nonmalignant diseases, and patients with a variety of metastatic carcinomas. EXPERIMENTAL DESIGN: The CellSearch system was used to enumerate CTCs in 7.5 mL of blood. Blood samples spiked with cells from tumor cell lines were used to establish analytical accuracy, reproducibility, and linearity. Prevalence of CTCs was determined in blood from 199 patients with nonmalignant diseases, 964 patients with metastatic carcinomas, and 145 healthy donors. RESULTS: Enumeration of spiked tumor cells was linear over the range of 5 to 1,142 cells, with an average recovery of >/=85% at each spike level. Only 1 of the 344 (0.3%) healthy and nonmalignant disease subjects had >/=2 CTCs per 7.5 mL of blood. In 2,183 blood samples from 964 metastatic carcinoma patients, CTCs ranged from 0 to 23,618 CTCs per 7.5 mL (mean, 60 +/- 693 CTCs per 7.5 mL), and 36% (781 of 2,183) of the specimens had >/=2 CTCs. Detection of >/=2 CTCs occurred at the following rates: 57% (107 of 188) of prostate cancers, 37% (489 of 1,316) of breast cancers, 37% (20 of 53) of ovarian cancers, 30% (99 of 333) of colorectal cancers, 20% (34 of 168) of lung cancers, and 26% (32 of 125) of other cancers. CONCLUSIONS: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs. CTCs are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-04-0378

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Statistics for Experimenters
Addelman, S., Box, G. E. P., Hunter, W. G., & Hunter, J. S. (1979) · Technometrics · doi:10.2307/1267766 · Cited by 6,753
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Detection and characterization of carcinoma cells in the blood
Racila, E. V., Euhus, D., Weiss, A. J., Rao, C., McConnell, J. D., Terstappen, L. W. M. M., & Uhr, J. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4589 · Cited by 713
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
Ross, A., Cooper, B., Lazarus, H. M., Mackay, W., Moss, T., Ciobanu, N., Tallman, M. S., Kennedy, M., Davidson, N., & Sweet, D. (1993) · Blood · doi:10.1182/blood.v82.9.2605.bloodjournal8292605 · Cited by 487
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., Weber, F., Mertelsmann, R. H., & Kanz, L. (1994) · Blood · doi:10.1182/blood.v83.3.636.636 · Cited by 440
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., et al. (1994) · Blood · doi:10.1182/blood.v83.3.636.bloodjournal833636 · Cited by 357
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues.
Momburg, F., Moldenhauer, G., Hämmerling, G. J., & Möller, P. (1987) · PubMed · Cited by 328
Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., & Uchitomi, Y. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12 · Cited by 309
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
Borgen, E., Naume, B., Nesland, J. M., Kvalheim, G., Beiske, K., Fodstad, Ø., Diel, I., Solomayer, E., Theocharous, P., Coombes, R. C., et al. (1999) · Cytotherapy · doi:10.1080/0032472031000141283 · Cited by 263

Show all 30 references

Research works printed but not linked: 8

Soria JC, Gauthier LR, Raymond E, et al Molecular detection of telomerase positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 1999;5:971-5.
Fehm T, Sagalowsky A, Clifford E, et al Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002;8:2073-84.
Kagan M, Howard D, Bendele T, et al A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 2002;25:104-10.
Rao C, Rutner H, Hermann M, Russell T, Terstappen LWMM. Preservation of blood specimens to prevent breakdown of circulating tumor cells. Proc Am Assoc Cancer Res 2002;43:734
Allard WJ, Hayes DF, Repollet MI, et al A cellular preservative improves the specificity and yield of circulating tumor cells in carcinoma patients[abstract A3482]. Proc Am Soc Clin Oncol 2003;22:866
Motulsky H. The confidence interval of counted variables. Intuitive biostatistics 1995p. 245-9. Oxford University Press New York
Miller MC, Gross S, Allard WJ, et al Circulating tumor cells (CTCs) predict survival in patients with metastatic prostate cancer[abstract A5270]. Proc Am Assoc Cancer Res 2004;45:1215
Cristofanilli M, Reuben JM, Fritsche HA, et al Circulating tumor cells (CTCs): a novel prognostic factor for newly diagnosed metastatic breast cancer (MBC)[abstract A1349]. Proc Am Assoc Cancer Res 2003;44:1349

Sorted by citations

Items 101–200 of 1,004

In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
He, W., Wang, H., Hartmann, L. C., Cheng, J., & Low, P. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703875104 · Cited by 292
Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
Mostert, B., Sleijfer, S., Foekens, J. A., & Gratama, J. W. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.03.004 · Cited by 284
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
Pierga, J., Hajage, D., Bachelot, T., Delaloge, S., Brain, E. G. C., Campone, M., Dieras, V. C., Rolland, E., Mignot, L., Mathiot, C., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr263 · Cited by 281
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
Bidard, F., Michiels, S., Riethdorf, S., Müller, V., Esserman, L. J., Lucci, A., Naume, B., Horiguchi, J., Gisbert‐Criado, R., Sleijfer, S., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy018 · Cited by 278
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
Autio, K. A., Dreicer, R., Anderson, J., Garcia, J. A., Alva, A. S., Hart, L. L., Milowsky, M. I., Posadas, E. M., Ryan, C. J., Graf, R. P., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2168 · Cited by 288
Circulating biomarkers for early detection and clinical management of colorectal cancer
Marcuello, M., Vymetalkova, V. P., Neves, R. P., Durán-Sanchón, S., Vedeld, H. M., Tham, E., van Dalum, G., Flügen, G., García‐Barberán, V., Fijneman, R. J. A., et al. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.06.002 · Cited by 283
Clinical applications of the CellSearch platform in cancer patients
Riethdorf, S., O′Flaherty, L., Hille, C., & Pantel, K. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.011 · Cited by 278
Circulating giant macrophages as a potential biomarker of solid tumors
Adams, D. L., Martin, S. S., Alpaugh, R. K., Charpentier, M. S., Tsai, S., Bergan, R. C., Ogden, I., Catàlona, W. J., Chumsri, S., Tang, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320198111 · Cited by 272
Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
Haluska, P., Shaw, H. M., Batzel, G. N., Yin, D., Molina, J. R., Molife, L. R., Yap, T. A., Roberts, M. L., Sharma, A., Gualberto, A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1118 · Cited by 269
Lymphatic or Hematogenous Dissemination: How Does a Metastatic Tumor Cell Decide?
Wong, S. Y., & Hynes, R. O. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2646 · Cited by 277
Imaging pH and metastasis
Hashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V., & Gillies, R. J. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1644 · Cited by 265
Circulating tumour cells: their utility in cancer management and predicting outcomes
Krebs, M., Hou, J., Ward, T. H., Blackhall, F. H., & Dive, C. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010378414 · Cited by 269
Cancer Diagnosis: From Tumor to Liquid Biopsy and Beyond
Vaidyanathan, R., Soon, R. H., Zhang, P., Jiang, K., & Lim, C. T. (2018) · Lab on a Chip · doi:10.1039/c8lc00684a · Cited by 267
Capture, Release and Culture of Circulating Tumor Cells from Pancreatic Cancer Patients using an Enhanced Mixing Chip
Sheng, W.-A., Ogunwobi, O., Chen, T., Zhang, J.-L., George, T., Liu, C., & Fan, Z. H. (2013) · Lab on a Chip · doi:10.1039/c3lc51017d · Cited by 235
Circulating Epithelial Cells in Patients with Benign Colon Diseases
Pantel, K., Denève, E., Nocca, D., Coffy, A., Vendrell, J.-P., Maudelondé, T., Riethdorf, S., & Alix‐Panabières, C. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.175570 · Cited by 254
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
Khoja, L., Backen, A. C., Sloane, R. A. S., Menasce, L. P., Ryder, W. D. J., Krebs, M., R Board, Clack, G., Hughes, A. M., Blackhall, F. H., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.545 · Cited by 266
Molecular profiling of single circulating tumor cells with diagnostic intention
Polzer, B., Medoro, G., Pasch, S., Fontana, F., Zorzino, L., Pestka, A., Andergassen, U., Meier-Stiegen, F., Czyż, Z. T., Alberter, B., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404033 · Cited by 267
Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
Mikolajczyk, S. D., Millar, L. S., Tsinberg, P., Coutts, S. M., Zomorrodi, M., Pham, T., Bischoff, F. Z., & Pircher, T. J. (2011) · Journal of Oncology · doi:10.1155/2011/252361 · Cited by 254
Circulating biomarkers in patients with glioblastoma
Bark, J. M., Kulasinghe, A., Chua, B., Day, B. W., & Punyadeera, C. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0603-6 · Cited by 262
Circulating tumour cells in clinical practice: Methods of detection and possible characterization
Alunni‐Fabbroni, M., & Sandri, M. T. (2010) · Methods · doi:10.1016/j.ymeth.2010.01.027 · Cited by 254
Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
Madhavan, D., Zucknick, M., Wallwiener, M., Ćuk, K., Modugno, C., Scharpff, M., Schott, S., Heil, J., Turchinovich, A. A., Yang, R., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1407 · Cited by 251
Emerging Role of Nanomaterials in Circulating Tumor Cell Isolation and Analysis
Yoon, H. J., Kozminsky, M., & Nagrath, S. (2014) · ACS Nano · doi:10.1021/nn5004277 · Cited by 245
Circulating Tumor Cells and Bone Marrow Micrometastasis
Alix‐Panabières, C., Riethdorf, S., & Pantel, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5125 · Cited by 245
Circulating Tumor Cells as Biomarkers in Prostate Cancer
Danila, D. C., Fleisher, M., & Scher, H. I. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2650 · Cited by 244
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
Olmos, D., Arkenau, H., Ang, J. E., Ledaki, I., Attard, G., Carden, C. P., Reid, A. H. M., A’Hern, R., Fong, P. C. C., Oommen, N. B., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn544 · Cited by 243
Circulating tumor cell isolation, culture, and downstream molecular analysis
Sharma, S., Zhuang, R., Long, M., Pavlović, M. D., Kang, Y., Ilyas, A., & Asghar, W. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.007 · Cited by 247
Human dental pulp stem cells: Applications in future regenerative medicine
Potdar, P. D. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i5.839 · Cited by 240
Single‐cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT‐related genes in metastatic prostate cancer
Chen, C., Mahalingam, D., Osmulski, P. A., Jadhav, R. R., Wang, C. M., Leach, R. J., Chang, T. A., Weitman, S. D., Kumar, A. P., Sun, L., et al. (2012) · The Prostate · doi:10.1002/pros.22625 · Cited by 246
Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy
Hou, J., Greystoke, A., Lancashire, L., Cummings, J., Ward, T. H., Ruth Board, Amir, E., Hughes, S., Krebs, M., Hughes, A. M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090078 · Cited by 238
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
Hong, X., Roh, W., Sullivan, R. J., Wong, K. H. K., Wittner, B. S., Guo, H., Dubash, T. D., Sade-Feldman, M., Wesley, B., Horwitz, E. P., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1500 · Cited by 243
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
Bidard, F., Mathiot, C., Delaloge, S., Brain, E. G. C., Giachetti, S., de Crémoux, P., Marty, M. E., & Pierga, J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp391 · Cited by 232
Biomimetic Immuno‐Magnetosomes for High‐Performance Enrichment of Circulating Tumor Cells
Xiong, K., Wei, W., Jin, Y., Wang, S., Zhao, D., Wang, S., Gao, X., Qiao, C.-M., Yue, H., Ma, G., et al. (2016) · Advanced Materials · doi:10.1002/adma.201601643 · Cited by 230
High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery
Yang, X., Kui, L., Tang, M., Li, D., Wei, K., Chen, W., Miao, J., & Dong, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00019 · Cited by 231
Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
Morgan, T. M., Lange, P. H., Porter, M. P., Lin, D. W., Ellis, W. J., Gallaher, I. S., & Vessella, R. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1754 · Cited by 229
Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells
Bonnomet, A., Brysse, A., Tachsidis, A., Waltham, M. C., Thompson, E. W., Polette, M., & Gilles, C. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9174-0 · Cited by 232
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
Hiltermann, T. J. N., Pore, M. M., van den Berg, A., Timens, W., Boezen, H. M., Liesker, J. J. W., Schouwink, J. H., Wijnands, W. J. A., Kerner, G. S. M. A., Kruyt, F. A. E., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds138 · Cited by 225
Microfluidic Isolation of Circulating Tumor Cell Clusters by Size and Asymmetry
Au, S. H., Edd, J., Stoddard, A. E., Wong, K. H. K., Fachin, F., Maheswaran, S., Haber, D. A., Stott, S. L., Kapur, R., & Toner, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01150-3 · Cited by 225
Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
Dasgupta, A., Lim, A. R., & Ghajar, C. M. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12022 · Cited by 225
NanoFlares for the detection, isolation, and culture of live tumor cells from human blood
Halo, T. L., McMahon, K. M., Angeloni, N. L., Xu, Y., Wang, W., Chinen, A. B., Malin, D., Strekalova, E., Cryns, V. L., Cheng, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418637111 · Cited by 222
Circulating tumor cells: clinical validity and utility
Cabel, L., Proudhon, C., Gortais, H., Loirat, D., Coussy, F., Pierga, J., & Bidard, F. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1105-2 · Cited by 223
Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
Giordano, A., Gao, H., Anfossi, S., Cohen, E. N., Mego, M., Lee, B.-N., Tin, S., Laurentiis, M. D., Parker, C. A., Álvarez, R. H., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0460 · Cited by 220
Microfluidics and circulating tumor cells.
Dong, Y., Skelley, A., Merdek, K., Sprott, K., Jiang, C.-S., Pierceall, W., Lin, J., Stocum, M., Carney, W., & Smirnov, D. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.09.004 · Cited by 206
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Giuliano, M., Giordano, A., Jackson, S. A., Hess, K. R., Giorgi, U. D., Mego, M., Handy, B. C., Ueno, N. T., Álvarez, R. H., Laurentiis, M. D., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2907 · Cited by 223
A Novel Platform for Detection of CK+ and CK− CTCs
Pecot, C. V., Bischoff, F. Z., Mayer, J. A., Wong, K. L., Pham, T., Bottsford-Miller, J. N., Stone, R. L., Lin, Y. G., Jaladurgam, P., Roh, J., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0215 · Cited by 221
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring
Batool, S. M., Yekula, A., Khanna, P., Hsia, T., Gamblin, A. S., Ekanayake, E., Escobedo, A. K., You, D. G., Castro, C. M., Im, H., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101198 · Cited by 221
Label-Free Cancer Cell Separation from Human Whole Blood Using Inertial Microfluidics at Low Shear Stress
Lee, M. G., Shin, J. H., Bae, C. Y., Choi, S., & Park, J. (2013) · Analytical Chemistry · doi:10.1021/ac4006149 · Cited by 215
Statistical considerations for enumeration of circulating tumor cells
Tibbe, A. G. J., Miller, M. C., & Terstappen, L. W. M. M. (2007) · Cytometry Part A · doi:10.1002/cyto.a.20369 · Cited by 215
Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables
Sastre, J., Maestro, M. L., Puente, J., Veganzones, S., Alfonso, R., Rafael, S., García-Sáenz, J. Á., Vidaurreta, M., Martín, M., Arroyo, M., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm583 · Cited by 215
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
Tol, J. A. M. G., Koopman, M., Miller, M. C., Tibbe, A. G. J., Cats, A., Creemers, G. J. M., Vos, A. H., Nagtegaal, I. D., Terstappen, L. W. M. M., & Punt, C. J. A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp463 · Cited by 215
Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system
Andreopoulou, E., Yang, L. ‐., Rangel, K. M., Reuben, J. M., Hsu, L., Krishnamurthy, S., Valero, V., Fritsche, H. A., & Cristofanilli, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26111 · Cited by 214
Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research
Grover, P. K., Cummins, A. G., Price, T. J., Roberts‐Thomson, I. C., & Hardingham, J. E. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu018 · Cited by 215
TRAIL-coated leukocytes that kill cancer cells in the circulation
Mitchell, M. J., Wayne, E. C., Rana, K., Schaffer, C. B., & King, M. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316312111 · Cited by 213
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study
Behbakht, K., Sill, M. W., Darcy, K. M., Rubin, S. C., Mannel, R. S., Waggoner, S. E., Schilder, R. J., Cai, K. Q., Godwin, A. K., & Alpaugh, R. K. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.06.022 · Cited by 214
All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer
Coumans, F. A. W., Doggen, C. J. M., Attard, G., Bono, J. S. D., & Terstappen, L. W. M. M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq030 · Cited by 211
Programmable Fractal Nanostructured Interfaces for Specific Recognition and Electrochemical Release of Cancer Cells
Zhang, P., Chen, L., Xu, T., Liu, H., Liu, X., Meng, J., Gao, Y., Jiang, L., & Wang, S. (2013) · Advanced Materials · doi:10.1002/adma.201300888 · Cited by 211
Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications
Jie, X., Zhang, X., & Xu, C. (2017) · Oncotarget · doi:10.18632/oncotarget.18277 · Cited by 215
Circulating Tumor Cells: A Multifunctional Biomarker
Yap, T. A., Lorente, D., Omlin, A. G., Olmos, D., & Bono, J. S. D. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2664 · Cited by 214
Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay
Harb, W. A., Fan, A. R., Tran, T. T., Danila, D. C., Keys, D. N., Schwartz, M. A., & Ionescu‐Zanetti, C. (2013) · Translational Oncology · doi:10.1593/tlo.13367 · Cited by 211
Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?
Gold, B., Cankovic, M., Furtado, L. V., Meier, F. A., & Gocke, C. D. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.02.001 · Cited by 215
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours
Zhu, Z., Achreja, A., Meurs, N., Animasahun, O., Owen, S., Mittal, A., Parikh, P., Lo, T.-W., Franco-Barraza, J., Shi, J., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0226-5 · Cited by 204
Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients
Tan, S. J., Lakshmi, R. L., Chen, P., Lim, W., Yobaş, L., & Lim, C. T. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.07.054 · Cited by 203
HER2-Positive Circulating Tumor Cells in Breast Cancer
Ignatiadis, M., Rothé, F., Chaboteaux, C., Durbecq, V., Rouas, G., Criscitiello, C., Metallo, J., Kheddoumi, N., Singhal, S. K., Michiels, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015624 · Cited by 203
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
Pestrin, M., Bessi, S., Galardi, F., Truglia, M., Biggeri, A., Biagioni, C., Cappadona, S., Biganzoli, L., Giannini, A., & Leo, A. D. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0461-7 · Cited by 201
The challenge of targeting cancer stem cells to halt metastasis
Agliano, A., Calvo, A., & Box, C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.003 · Cited by 201
Clinical utility of circulating tumor cells: an update
Vasseur, A., Kiavué, N., Bidard, F., Pierga, J., & Cabel, L. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12869 · Cited by 204
A Review of Circulating Tumour Cell Enrichment Technologies
Rushton, A. J., Nteliopoulos, G., Shaw, J., & Coombes, R. C. (2021) · Cancers · doi:10.3390/cancers13050970 · Cited by 204
Future medical applications of single-cell sequencing in cancer
Navin, N. E., & Hicks, J. B. (2011) · Genome Medicine · doi:10.1186/gm247 · Cited by 200
Advanced liquid biopsy technologies for circulating biomarker detection
Soda, N., Rehm, B. H. A., Sonar, P. M., Nguyen, N., & Shiddiky, M. J. A. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01490j · Cited by 205
Circulating Tumor Cell Analysis: Technical and Statistical Considerations for Application to the Clinic
Allan, A. L., & Keeney, M. (2009) · Journal of Oncology · doi:10.1155/2010/426218 · Cited by 203
Detection of circulating tumor cells: opportunities and challenges
Ju, S., Chen, C., Zhang, J., Xu, L. H., Zhang, X., Li, Z., Chen, Y., Zhou, J., Ji, F., & Wang, L. (2022) · Biomarker Research · doi:10.1186/s40364-022-00403-2 · Cited by 203
Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study
Bork, U., Rahbari, N. N., Schölch, S., Reißfelder, C., Kahlert, C., Büchler, M. W., Weitz, J., & Koch, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.88 · Cited by 196
Circulating tumor cells: the ‘leukemic phase’ of solid cancers
D, S. M. M., Keilholz, U., Rossi, C. R., & Nitti, D. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.01.006 · Cited by 196
Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies
Yap, T. A., Olmos, D., Brunetto, A. T., Tunariu, N., Barriuso, J., Riisnaes, R., Pope, L., Clark, J., Futreal, P. A., Germuska, M. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.0367 · Cited by 196
Circulating Tumor Cell Enumeration with a Combination of Epithelial Cell Adhesion Molecule– and Cell-Surface Vimentin–Based Methods for Monitoring Breast Cancer Therapeutic Response
Satelli, A., Brownlee, Z., Mitra, A., Meng, Q. H., & Li, S. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.228122 · Cited by 195
Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
Harouaka, R. A., Kang, Z., Zheng, S.-Y., & Cao, L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.004 · Cited by 200
Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments
Jin, C., McFaul, S. M., Duffy, S. P., Deng, X., Tavassoli, P., Black, P. C., & Ma, H. (2013) · Lab on a Chip · doi:10.1039/c3lc50625h · Cited by 196
TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Danila, D. C., Anand, A., Sung, C. C., Heller, G., Leversha, M. A., Cao, L., Lilja, H. G., Molina, A., Sawyers, C. L., Fleisher, M., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.07.011 · Cited by 193
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
Bidard, F., Huguet, F., Louvet, C., Mineur, L., Bouché, O., Chibaudel, B., Artru, P., Desseigne, F., Bachet, J., Mathiot, C., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt176 · Cited by 192
Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor
Bono, J. S. D., Attard, G., Adjei, A. A., Pollak, M., Fong, P. C. C., Haluska, P., Roberts, L., Melvin, C. L., Repollet, M., Chianese, D. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0268 · Cited by 192
Clinical application and detection techniques of liquid biopsy in gastric cancer
Ma, S., Zhou, M., Xu, Y., Gu, X., Zou, M., Abudushalamu, G., Yao, Y., Fan, X., & Wu, G. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01715-z · Cited by 203
Challenges in the Enumeration and Phenotyping of CTC
Coumans, F. A. W., Ligthart, S. T., Uhr, J. W., & Terstappen, L. W. M. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1585 · Cited by 190
Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells
Książkiewicz, M., Markiewicz, A., & Zaczek, A. J. (2012) · Pathobiology · doi:10.1159/000337106 · Cited by 192
Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
Rink, M., Chun, F. K. ‐., Dahlem, R., Soave, A., Minner, S. J. P., Hansen, J., Stoupiec, M., Coith, C., Kluth, L. A., Ahyai, S., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.01.017 · Cited by 190
The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients
Sequist, L. V. D., Nagrath, S., Toner, M., Haber, D. A., & Lynch, T. J. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181989565 · Cited by 194
Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients
Liu, Z., Fusi, A., Klopocki, E., Schmittel, A. H., Tinhofer, I., Nonnenmacher, A., & Keilholz, U. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-70 · Cited by 197
Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer
Cohen, S. J., Alpaugh, R. K., Gross, S., O'Hara, S. M., Smirnov, D. A., Terstappen, L. W. M. M., Allard, W. J., Bilbee, M., Cheng, J. D., Hoffman, J. P., et al. (2006) · Clinical Colorectal Cancer · doi:10.3816/ccc.2006.n.029 · Cited by 189
Detection and isolation of circulating tumor cells: Principles and methods
Esmaeilsabzali, H., Beischlag, T. V., Cox, M., Parameswaran, A. M., & Park, E. J. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.016 · Cited by 194
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Leversha, M. A., Han, J., Asgari, Z., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Anand, A., Lilja, H. G., Heller, G., Fleisher, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2036 · Cited by 188
Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer
Franken, B., de Groot, M. R., MASTBOOM, W. J. B., Vermes, I., van der Palen, J. A. M., Tibbe, A. G. J., & Terstappen, L. W. M. M. (2012) · Breast Cancer Research · doi:10.1186/bcr3333 · Cited by 189
Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
Naito, T., Tanaka, F., Ono, A., Yoneda, K., Takahashi, T., Murakami, H., Nakamura, Y., Tsuya, A., Kenmotsu, H., Shukuya, T., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823f125d · Cited by 186
Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells
Lim, L. S., Hu, M. S., Huang, M. C., Cheong, W. C., Gan, A. T. L., Looi, X. L., Leong, S. M., Koay, E. S.-C., & Li, M. (2012) · Lab on a Chip · doi:10.1039/c2lc20750h · Cited by 190
Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers
Hiraiwa, K., Takeuchi, H., Hasegawa, H., Saikawa, Y., Suda, K., Ando, T., Kumagai, K., Irino, T., Yoshikawa, T., Matsuda, S., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0122-9 · Cited by 186
Molecular characterization of breast cancer CTCs associated with brain metastasis
Boral, D., Vishnoi, M., Liu, H. N., Yin, W., Sprouse, M. L., Scamardo, A. T., Hong, D. S., Tan, T. Z., Thiery, J. P., Chang, J. C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00196-1 · Cited by 191
Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance
Sun, Y., Yang, X., Zhou, J., Qiu, S., Fan, J., & Xu, Y. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-0988-y · Cited by 187
Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
Khan, M. S., Kirkwood, A. A., Tsigani, T., García-Hernández, J., Hartley, J. A., Caplin, M. E., & Meyer, T. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.2905 · Cited by 184
Molecular heterogeneity in breast cancer: State of the science and implications for patient care
Ellsworth, R. E., Blackburn, H. L., Shriver, C. D., Soon‐Shiong, P., & Ellsworth, D. L. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.025 · Cited by 191
Continuous flow microfluidic separation and processing of rare cells and bioparticles found in blood – A review
Antfolk, M., & Laurell, T. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.02.017 · Cited by 187
Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?
Martin, O. A., Anderson, R. L., Narayan, K., & MacManus, M. P. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.128 · Cited by 184
Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
Bidard, F., Jacot, W., Kiavué, N., Dureau, S., Kadi, A., Brain, E. G. C., Bachelot, T., Bourgeois, H. P., Gonçalvès, A., Ladoire, S., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.5660 · Cited by 192
From Nanotechnology to Nanomedicine: Applications to Cancer Research
Seigneuric, R., Markey, L., Nuyten, D. S. A., Dubernet, C., Evelo, C. T., Finot, É., & Garrido, C. (2010) · Current Molecular Medicine · doi:10.2174/156652410792630634 · Cited by 191

Authors: Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M.
Affiliations: 1Immunicon Corporation, Huntingdon Valley, Pennsylvania; and
The University of Texas Southwestern Medical Center (US)
ORCID: Miller, M. Craig
Terstappen, Leon W. M. M.
Venue: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2004-10-15
Volume: 10
Issue: 20
Pages: 6897-6904
ISSN: 1078-0432 (ISSN-L)
1557-3265
DOI: 10.1158/1078-0432.ccr-04-0378
OpenAlex: W2116483002
Cited by: 2,542
References: 30
Citations by year: 2026: 66 · 2025: 81 · 2024: 87 · 2023: 135 · 2022: 117 · 2021: 158 · 2020: 169 · 2019: 166 · 2018: 171 · 2017: 193 · 2016: 197 · 2015: 165 · 2014: 177 · 2013: 161 · 2012: 132
FWCI: 7.52
Type: journal article
Language: en
Open access: closed
Locations: Clinical Cancer Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
Keywords: circulating tumor cells, CellSearch, metastatic carcinoma, prostate cancer, breast cancer, ovarian cancer, colorectal cancer, lung cancer, liquid biopsy
MeSH terms: Adult, Automation, Biological Assay, Carcinoma, Cytological Techniques, Female, Humans, Male, Middle Aged, Neoplastic Cells, Circulating, Neoplasm Metastasis, Sensitivity and Specificity, Reproducibility of Results, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks